Director of General Ledger & Financial Close

Revolution Medicines; San Francisco (CA); On-site; USD 211,000 - 264,000; Full time

Job summary

Revolution Medicines, a global oncology company, seeks an experienced Director of Accounting to lead US general ledger and close processes. You will develop a high-performing team, strengthen internal controls under SOX, and partner with Finance, Tax, FP&A and IT to ensure accurate financial reporting in a scalable framework.

The role requires 10+ years in accounting, US GAAP expertise, and public company experience.

Qualifications

• Bachelor’s degree in accounting, Finance, Business Administration, or a related field.
• 10+ years of progressive accounting experience, including significant general ledger and financial close experience and demonstrated people leadership.
• Strong knowledge of U.S. GAAP, general ledger accounting, account reconciliations, financial close processes, and internal controls.
• Experience working in a public company environment and with SOX compliance requirements.
• Demonstrated ability to lead, develop, and motivate high-performing accounting teams.

Responsibilities

• Lead the General Ledger Accounting function and oversee the monthly, quarterly, and annual financial close processes, ensuring timely, accurate, and complete financial results.
• Manage and develop General Ledger Accounting team members by establishing clear performance expectations, providing coaching and feedback, and fostering professional growth.
• Oversee journal entries, account reconciliations, accruals, prepaid expenses, fixed assets, intercompany transactions, equity and other general ledger activities.
• Ensure balance sheet accounts are appropriately reconciled, reviewed, and supported, with timely resolution of reconciling items.
• Partner with Financial Reporting and Technical Accounting teams to support quarterly and annual financial reporting requirements and ensure transactions are recorded in accordance with U.S. GAAP.
• Collaborate with Accounts Payable, Payroll, Procurement, Treasury, Tax, FP&A, and other functions to ensure accurate and complete accounting for business activities.
• Review accounting results and perform analytical reviews to identify unusual trends, variances, or accounting issues and ensure timely resolution.
• Develop, maintain, and strengthen internal controls over general ledger and financial close processes, ensuring compliance with SOX requirements and Company policies.
• Partner with the SOX Compliance team on control documentation, testing, remediation activities, user access reviews, and segregation-of-duties assessments for financial systems.
• Support internal and external audit activities related to general ledger accounts and close processes, coordinating audit requests and ensuring timely resolution of inquiries.
• Establish and monitor key performance indicators and close metrics to improve the timeliness, accuracy, and efficiency of the accounting close.
• Identify and implement process improvements, automation opportunities, and system enhancements to increase scalability, strengthen controls, and improve operational efficiency.
• Support accounting system implementations, finance transformation initiatives, acquisitions, integrations, and other cross-functional projects as needed.
• Maintain accounting policies, procedures, and documentation related to general ledger activities and ensure consistent application across the organization.
• Serve as a key accounting partner to business stakeholders, providing guidance on accounting processes, financial controls, and transaction-related matters.

Education

Bachelor’s degree in accounting, Finance, Business Administration, or a related field

Tools

NetSuite

Coupa

Job description

Revolution Medicines, a global oncology company, seeks an experienced Director of Accounting to lead US general ledger and close processes. You will develop a high-performing team, strengthen internal controls under SOX, and partner with Finance, Tax, FP&A and IT to ensure accurate financial reporting in a scalable framework.

The role requires 10+ years in accounting, US GAAP expertise, and public company experience.